Hetero Drugs Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 3.45 Cr
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 955.81 Cr
- Satisfied Charges ₹ 3,560.31 Cr
- Revenue Growth 19.76%
- Profit Growth 65.07%
- Ebitda 13.14%
- Net Worth 8.05%
- Total Assets 8.62%
About Hetero Drugs
Hetero Drugs Limited (HDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 06 April 1993 and has a history of 32 years and one month. Its registered office is in Rangareddy, Telangana, India.
The Corporate was formerly known as Hetero Drugs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 3.45 Cr.
The company currently has active open charges totaling ₹955.81 Cr. The company has closed loans amounting to ₹3,560.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hetero Drugs Limited India is Ravi Upputhalla as COMPANY SECRETARY. Parthasaradhi Bandi, Attunuri Reddy, Kalavathi Bandi, and Five other members serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230TG1993PLC015582
- Company No.
015582
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Apr 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
What products or services does Hetero Drugs Limited offer?
Hetero Drugs Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Antiviral Drugs, HIV Drugs, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pharma & Bioanalytical Services, PCD Pharma Franchise, Apparel & Textile Machinery, Textile Finishing Machine.
Hetero Drugs Limited
Explore comprehensive data for Hetero Drugs Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Hetero Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Upputhalla  | Company Secretary | 03-Sep-2018 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parthasaradhi Bandi | Director | 01-Apr-2008 | Current |
| Attunuri Reddy | Director | 28-Jan-1999 | Current |
| Kalavathi Bandi | Director | 01-Apr-2015 | Current |
| Sambi Jonnala | Whole-Time Director | 18-Nov-1999 | Current |
| Rathnakar Kura | Director | 28-Nov-2013 | Current |
| Bandi Vamsikrishna | Director | 10-Apr-2008 | Current |
Financial Performance of Hetero Drugs.
Hetero Drugs Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.76% increase. The company also saw a substantial improvement in profitability, with a 65.07% increase in profit. The company's net worth moved up by a moderate rise of 8.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hetero Drugs?
In 2023, Hetero Drugs had a promoter holding of 76.24% and a public holding of 23.76%. The company had 5 Subsidiaries and 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hindys Lab Private LimitedSambi Jonnala is a mutual person
Hetero Marbles Private LimitedBandi Vamsikrishna is a mutual person
- Hetero Labs Limited
Parthasaradhi Bandi, Attunuri Reddy and 2 more are mutual person
- Hetero Biopharma Limited
Parthasaradhi Bandi and Bandi Vamsikrishna are mutual person
- Hetero Wind Power Limited
Kalavathi Bandi and Bandi Vamsikrishna are mutual person
- Hetero Infrastructure Sez Private Limited
Sambi Jonnala and Rathnakar Kura are mutual person
Charges (Loans)
Open Charges
₹955.81 Cr
Satisfied Charges
₹3,560.31 Cr
Charges Breakdown by Lending Institutions
- Idbi Trusteeship Services Limited : 700.00 Cr
- State Bank Of India : 150.00 Cr
- Industrial Development Bank Of India : 81.00 Cr
- Idbi Bank : 15.61 Cr
- Others : 6.14 Cr
- Others : 3.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2024 | State Bank Of India | ₹150.00 Cr | Open |
| 23 Jan 2023 | Others | ₹0.90 M | Open |
| 29 Sep 2022 | Others | ₹1.06 M | Open |
| 29 Sep 2022 | Others | ₹1.10 M | Open |
| 27 Jul 2022 | Others | ₹1.57 Cr | Open |
How Many Employees Work at Hetero Drugs?
Hetero Drugs has a workforce of 1711 employees as of Jul 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hetero Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetero Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Hetero Drugs
Recent activity within the organization
- Charges
A charge with State Bank Of India amounted to Rs. 150.00 Cr with Charge ID 100901020 was registered on 21 Mar 2024.
- Charges
A charge registered on 28 Jun 2023 via Charge ID 100747075 with State Bank Of India was fully satisfied on 05 Feb 2024.
- Director Appointment
Gopal Reddy Annareddy was appointed as a Director was appointed as a Director on 12 Jan 2024 & has been associated with this company since 1 year 4 months .
- Charges
A charge with Idbi Trusteeship Services Limited of Rs. 700.00 Cr registered on 21 Oct 2021 with Charge ID 100510794 was modified on 29 Dec 2023.
- Annual General Meeting
Hetero Drugs Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Charges
A charge with State Bank Of India amounted to Rs. 315.00 Cr with Charge ID 100747075 was registered on 28 Jun 2023.
Recent News, Updates & Announcement
Latest ARB Recall Triggered by New Impurity.Hetero Labs recalls losartan potassium tablets due to presence of N-Nitroso-N-methyl-4-aminobutyric acid..
- New cancer-causing toxin found in recalled blood pressure pills.
The U.S. Food and Drug Administration is also looking into whether these types of impurities could be found in other classes of drugs, a spokeswoman for the regulator said..
- Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API).
/PRNewswire/ -- Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted....
- Hetero launches generic breast cancer treatment drug in India.
Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country..
- Hetero Labs Limited acquires Tarbis Farma in Spain.
The acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio, manpower and a seamless entry into the Retail, Hospital and Tender business channels in Spain..
Frequently asked questions
What is the Incorporation or founding date of Hetero Drugs Limited?
Hetero Drugs Limited was incorporated on 06 Apr 1993.
What is authorized share capital and paid-up capital of Hetero Drugs Limited?
The authorized share capital of Hetero Drugs Limited is ₹ 10.00 Cr and paid-up capital is ₹ 3.45 Cr.
Who are the current board members & directors of Hetero Drugs Limited?
Currently 9 directors are associated with Hetero Drugs Limited.
- Parthasaradhi Reddy Bandi
- Attunuri Venkatanarasa Reddy
- Kalavathi Bandi
- Sambi Reddy Jonnala
- Rathnakar Reddy Kura
- Bandi Vamsikrishna
- Gopal Reddy Annareddy
- Adisesha Giri Jagarapu
- Ravi Kumar Upputhalla
What is the registered address of Hetero Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Hetero Drugs Limited is 7-2-A2 Industrial Estate Sanathnagar, India, Balanagar, Telangana, 500018.
What is the corporate identification number (CIN) and company number of Hetero Drugs Limited?
The corporate identification number (CIN) of Hetero Drugs Limited is U24230TG1993PLC015582 and the company number is 015582 as per Ministry of Corporate Affairs (MCA).
What is the official website of Hetero Drugs Limited?
The Official website of Hetero Drugs Limited is https://www.hetero.com
What has been the recent revenue trend for Hetero Drugs Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Hetero Drugs Limited has risen by 19.76%.
How many employees does Hetero Drugs Limited currently have?
As Per 2023 financial reports, 1711 employees are currently employed by Hetero Drugs Limited.
What change has been observed in the net worth of Hetero Drugs Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Hetero Drugs Limited has experienced an upsurge of 8.05%.
What are the total open charges for Hetero Drugs Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Hetero Drugs Limited amount to ₹ 955.81 Cr.
When was the last Balance Sheet of Hetero Drugs Limited filed with the ROC?
The most recent Balance Sheet for Hetero Drugs Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Reddy NarsimhaDirector
Gopala RampalliDirectorVR
Vasu ReddysabbellaCompany SecretarySM
Srinivas MaleDirectorBR
Bhimavarapu ReddyWhole-Time DirectorMR
Mareddy ReddyDirectorBC
Bhaskar ChilukaWhole-Time DirectorVK
Vijaya KesariWhole-Time Director
Similar Companies Based on API Manufacturers
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Msn Laboratories Private Limited Rangareddy, Telangana, India
Lupin Limited Mumbai, Maharashtra, India
Ipca Laboratories Limited Mumbai, Maharashtra, India
Divi's Laboratories Limited Rangareddy, Telangana, India- Hetero Labs Limited Rangareddy, Telangana, India
Glenmark Pharmaceuticals Limited Mumbai, Maharashtra, India